Xilingio 10mg/5mg Tablet
By Xilingio
Rx
10 Tablet in a Strip

Composition
Empagliflozin(10mg) + Linagliptin(5mg)

Manufacturer - Torrent Pharmaceuticals Ltd
Off. Ashram Road, Ahmedabad - 380 009., Gujarat, India

Expires on or after
September, 2025

liver
Xilingio 10mg/5mg Tablet is generally considered safe for use in patients with liver disease. It is advised that there is no need for dose adjustment when using this medication. However, it is important to note that the use of Xilingio 10mg/5mg Tablet is not recommended for individuals with severe hepatic impairment, as there have not been sufficient studies conducted in such cases. Always consult with your healthcare provider before using Xilingio 10mg/5mg Tablet, especially if you have severe liver issues.

kidney
Xilingio 10mg/5mg Tablet requires caution in patients with kidney disease. Dose adjustment may be necessary. Consult your doctor before use. Avoid in severe kidney disease or dialysis.

alcohol
It is advised to avoid consuming alcohol while taking Xilingio 10mg/5mg Tablet due to potential risks.

driving
It is not clear if Xilingio 10mg/5mg Tablet affects driving abilities. Avoid driving if you have symptoms impacting concentration and reaction time while using this medication.

pregnancy
Xilingio 10mg/5mg Tablet may not be safe to use during pregnancy. Animal studies have shown potential harm to the developing baby. Your doctor will assess the benefits and risks before prescribing. Please consult your doctor regarding its use during pregnancy.

breastfeeding
Xilingio 10mg/5mg Tablet may be unsafe while breastfeeding, as it could pass into breastmilk and harm the baby. It is advisable to consult a healthcare provider before using this medication during breastfeeding.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹788
Inclusive of all taxes
Content verified by

Dr. Preeti Kumar
MBBS, DGO - Obstetrics and Gynaecology, DNB - Obstetrics and Gynaecology
Last update on 01-Oct-2024